First Time Loading...

AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 6.63 USD 1.69% Market Closed
Updated: Apr 27, 2024
Section:
 

Wall Street
Price Targets

AXGN Price Targets Summary
AxoGen Inc

Wall Street analysts forecast AXGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXGN is 13.94 USD with a low forecast of 11.11 USD and a high forecast of 17.85 USD.

AXGN Lowest Forecast
Wall Street Target
11.11 USD
68% Upside
AXGN Average Forecast
Wall Street Target
13.94 USD
110% Upside
AXGN Highest Forecast
Wall Street Target
17.85 USD
169% Upside
Lowest
Price Target
11.11 USD
68% Upside
Average
Price Target
13.94 USD
110% Upside
Highest
Price Target
17.85 USD
169% Upside
AxoGen Inc Competitors:
Price Targets
301087
Cofoe Medical Technology Co Ltd
31% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
72% Upside
ELOS B
Elos Medtech AB
48% Downside
300318
Beijing Bohui Innovation Biotechnology Group Co Ltd
73% Upside
301087
Cofoe Medical Technology Co Ltd
31% Upside
EUZ
Eckert & Ziegler Strahlen und Medizintechnik AG
72% Upside
ELOS B
Elos Medtech AB
48% Downside
300318
Beijing Bohui Innovation Biotechnology Group Co Ltd
73% Upside
GN
GN Store Nord A/S
14% Upside
ELN
El En SpA
7% Upside
2190
Zylox-Tonbridge Medical Technology Co Ltd
51% Upside
B
301367
BMC Medical Co Ltd
83% Upside

Revenue
Forecast

Revenue Estimate
AxoGen Inc

For the last 8 years the compound annual growth rate for AxoGen Inc's revenue is 25%. The projected CAGR for the next 3 years is 13%.

25%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
51%
Average Beat
What are analyst estimates?

See Also

Summary
AXGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AXGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AXGN stock valuation using valuation multiples.
Wall Street Estimates
AXGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AXGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXGN's stock price target?
Price Target
13.94 USD

According to Wall Street analysts, the average 1-year price target for AXGN is 13.94 USD with a low forecast of 11.11 USD and a high forecast of 17.85 USD.

What is AxoGen Inc's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for AxoGen Inc's revenue is 25%. The projected CAGR for the next 3 years is 13%.

ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.